Cutler Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-800
| Closed | -$54K | – | 2653 |
|
2022
Q3 | $54K | Sell |
800
-442
| -36% | -$29.8K | ﹤0.01% | 864 |
|
2022
Q2 | $39K | Sell |
1,242
-16,295
| -93% | -$512K | ﹤0.01% | 963 |
|
2022
Q1 | $607K | Buy |
17,537
+17,337
| +8,669% | +$600K | 0.03% | 327 |
|
2021
Q4 | $5K | Sell |
200
-1,000
| -83% | -$25K | ﹤0.01% | 1830 |
|
2021
Q3 | $30K | Buy |
1,200
+55
| +5% | +$1.38K | ﹤0.01% | 1401 |
|
2021
Q2 | $40K | Sell |
1,145
-1,555
| -58% | -$54.3K | ﹤0.01% | 1317 |
|
2021
Q1 | $110K | Sell |
2,700
-2,215
| -45% | -$90.2K | 0.01% | 868 |
|
2020
Q4 | $212K | Buy |
4,915
+1,415
| +40% | +$61K | 0.01% | 557 |
|
2020
Q3 | $192K | Buy |
+3,500
| New | +$192K | 0.01% | 483 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 2285 |
|
2020
Q1 | – | Sell |
-800
| Closed | -$63K | – | 2244 |
|
2019
Q4 | $63K | Sell |
800
-1,300
| -62% | -$102K | ﹤0.01% | 817 |
|
2019
Q3 | $101K | Sell |
2,100
-1,400
| -40% | -$67.3K | 0.01% | 609 |
|
2019
Q2 | $184K | Buy |
3,500
+2,687
| +331% | +$141K | 0.02% | 499 |
|
2019
Q1 | $43K | Sell |
813
-9,440
| -92% | -$499K | ﹤0.01% | 882 |
|
2018
Q4 | $420K | Sell |
10,253
-747
| -7% | -$30.6K | 0.04% | 263 |
|
2018
Q3 | $418K | Buy |
11,000
+3,767
| +52% | +$143K | 0.03% | 388 |
|
2018
Q2 | $326K | Buy |
+7,233
| New | +$326K | 0.03% | 411 |
|
2018
Q1 | – | Sell |
-26,584
| Closed | -$1.05M | – | 2676 |
|
2017
Q4 | $1.05M | Buy |
26,584
+26,257
| +8,030% | +$1.03M | 0.04% | 237 |
|
2017
Q3 | $10K | Sell |
327
-6,534
| -95% | -$200K | ﹤0.01% | 1904 |
|
2017
Q2 | $187K | Sell |
6,861
-6,024
| -47% | -$164K | 0.01% | 897 |
|
2017
Q1 | $474K | Buy |
12,885
+11,129
| +634% | +$409K | 0.02% | 490 |
|
2016
Q4 | $25K | Buy |
1,756
+356
| +25% | +$5.07K | ﹤0.01% | 1819 |
|
2016
Q3 | $32K | Sell |
1,400
-200
| -13% | -$4.57K | ﹤0.01% | 1642 |
|
2016
Q2 | $26K | Sell |
1,600
-900
| -36% | -$14.6K | ﹤0.01% | 1696 |
|
2016
Q1 | $39K | Buy |
+2,500
| New | +$39K | ﹤0.01% | 1424 |
|